Dyslipidemia among patients with type 2 diabetes in Jordan: Prevalence, pattern, and associated factors
ObjectivesTo determine the prevalence and patterns of dyslipidemia and its associated risk factors among patients with type 2 diabetes attending the National Center for Diabetes, Endocrinology, and Genetics (NCDEG).MethodsA cross-sectional study was conducted at the NCDEG in Amman, Jordan. A total o...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-11-01
|
| Series: | Frontiers in Public Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2022.1002466/full |
| _version_ | 1811222510963785728 |
|---|---|
| author | Dana Hyassat Saba Al-Saeksaek Duha Naji Awn Mahasneh Yousef Khader Mousa Abujbara Mohammad El-Khateeb Kamel Ajlouni |
| author_facet | Dana Hyassat Saba Al-Saeksaek Duha Naji Awn Mahasneh Yousef Khader Mousa Abujbara Mohammad El-Khateeb Kamel Ajlouni |
| author_sort | Dana Hyassat |
| collection | DOAJ |
| description | ObjectivesTo determine the prevalence and patterns of dyslipidemia and its associated risk factors among patients with type 2 diabetes attending the National Center for Diabetes, Endocrinology, and Genetics (NCDEG).MethodsA cross-sectional study was conducted at the NCDEG in Amman, Jordan. A total of 971 patients with type 2 diabetes were included during the period September- December 2021. The socio-demographic data were collected through face-to-face interview questionnaire and anthropometric and clinical data were abstracted from medical records. The last three readings of lipid profile and HbA1C were abstracted from the medical records.ResultsThe overall prevalence of dyslipidemia among type 2 diabetic patients was 95.4%. The most common type of dyslipidemia was combined dyslipidemia (37.1%), with high triglycerides and low HDL-c (19.0%) being the most frequent type. Factors associated with hypercholesterolemia were diabetes duration ≤ 10 years, poor compliance to a statin, and HbA1c level (7–8%) (P-values: 0.008, 0.001, 0.021, respectively). Moreover, smoking and poor compliance with statin therapy were associated with high LDL-c level (P-values: 0.046 and 0.001, respectively). The presence of hypertension, high waist circumference, HbA1c level >8%, and diabetes duration ≤ 10 years were all associated with high triglyceride level (P-values: 0.008, 0.016, 0.011, and 0.018, respectively). Hypertension and HbA1c level >8% were associated with low HDL-c level (P-values: 0.010 and 0.011, respectively).ConclusionThe combination of high triglyceride and low HDL-c is the commonest lipid abnormality detected in patients with type 2 diabetes. An educational program that emphasizes the importance of adherence to a healthy lifestyle is strongly recommended. Further studies are needed to capture a wide range of factors that might influence dyslipidemia and glycemic control. |
| first_indexed | 2024-04-12T08:18:13Z |
| format | Article |
| id | doaj.art-ea701770c572480a887b35d70ca86fe6 |
| institution | Directory Open Access Journal |
| issn | 2296-2565 |
| language | English |
| last_indexed | 2024-04-12T08:18:13Z |
| publishDate | 2022-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Public Health |
| spelling | doaj.art-ea701770c572480a887b35d70ca86fe62022-12-22T03:40:44ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-11-011010.3389/fpubh.2022.10024661002466Dyslipidemia among patients with type 2 diabetes in Jordan: Prevalence, pattern, and associated factorsDana Hyassat0Saba Al-Saeksaek1Duha Naji2Awn Mahasneh3Yousef Khader4Mousa Abujbara5Mohammad El-Khateeb6Kamel Ajlouni7The National Center for Diabetes, Endocrinology, and Genetics, Amman, JordanThe National Center for Diabetes, Endocrinology, and Genetics, Amman, JordanThe National Center for Diabetes, Endocrinology, and Genetics, Amman, JordanThe National Center for Diabetes, Endocrinology, and Genetics, Amman, JordanDepartment of Public Health, Jordan University of Science and Technology (JUST), Irbid, JordanThe National Center for Diabetes, Endocrinology, and Genetics, Amman, JordanThe National Center for Diabetes, Endocrinology, and Genetics, Amman, JordanThe National Center for Diabetes, Endocrinology, and Genetics, Amman, JordanObjectivesTo determine the prevalence and patterns of dyslipidemia and its associated risk factors among patients with type 2 diabetes attending the National Center for Diabetes, Endocrinology, and Genetics (NCDEG).MethodsA cross-sectional study was conducted at the NCDEG in Amman, Jordan. A total of 971 patients with type 2 diabetes were included during the period September- December 2021. The socio-demographic data were collected through face-to-face interview questionnaire and anthropometric and clinical data were abstracted from medical records. The last three readings of lipid profile and HbA1C were abstracted from the medical records.ResultsThe overall prevalence of dyslipidemia among type 2 diabetic patients was 95.4%. The most common type of dyslipidemia was combined dyslipidemia (37.1%), with high triglycerides and low HDL-c (19.0%) being the most frequent type. Factors associated with hypercholesterolemia were diabetes duration ≤ 10 years, poor compliance to a statin, and HbA1c level (7–8%) (P-values: 0.008, 0.001, 0.021, respectively). Moreover, smoking and poor compliance with statin therapy were associated with high LDL-c level (P-values: 0.046 and 0.001, respectively). The presence of hypertension, high waist circumference, HbA1c level >8%, and diabetes duration ≤ 10 years were all associated with high triglyceride level (P-values: 0.008, 0.016, 0.011, and 0.018, respectively). Hypertension and HbA1c level >8% were associated with low HDL-c level (P-values: 0.010 and 0.011, respectively).ConclusionThe combination of high triglyceride and low HDL-c is the commonest lipid abnormality detected in patients with type 2 diabetes. An educational program that emphasizes the importance of adherence to a healthy lifestyle is strongly recommended. Further studies are needed to capture a wide range of factors that might influence dyslipidemia and glycemic control.https://www.frontiersin.org/articles/10.3389/fpubh.2022.1002466/fulldyslipidemiadiabeteslipid profileprevalenceassociated factors |
| spellingShingle | Dana Hyassat Saba Al-Saeksaek Duha Naji Awn Mahasneh Yousef Khader Mousa Abujbara Mohammad El-Khateeb Kamel Ajlouni Dyslipidemia among patients with type 2 diabetes in Jordan: Prevalence, pattern, and associated factors Frontiers in Public Health dyslipidemia diabetes lipid profile prevalence associated factors |
| title | Dyslipidemia among patients with type 2 diabetes in Jordan: Prevalence, pattern, and associated factors |
| title_full | Dyslipidemia among patients with type 2 diabetes in Jordan: Prevalence, pattern, and associated factors |
| title_fullStr | Dyslipidemia among patients with type 2 diabetes in Jordan: Prevalence, pattern, and associated factors |
| title_full_unstemmed | Dyslipidemia among patients with type 2 diabetes in Jordan: Prevalence, pattern, and associated factors |
| title_short | Dyslipidemia among patients with type 2 diabetes in Jordan: Prevalence, pattern, and associated factors |
| title_sort | dyslipidemia among patients with type 2 diabetes in jordan prevalence pattern and associated factors |
| topic | dyslipidemia diabetes lipid profile prevalence associated factors |
| url | https://www.frontiersin.org/articles/10.3389/fpubh.2022.1002466/full |
| work_keys_str_mv | AT danahyassat dyslipidemiaamongpatientswithtype2diabetesinjordanprevalencepatternandassociatedfactors AT sabaalsaeksaek dyslipidemiaamongpatientswithtype2diabetesinjordanprevalencepatternandassociatedfactors AT duhanaji dyslipidemiaamongpatientswithtype2diabetesinjordanprevalencepatternandassociatedfactors AT awnmahasneh dyslipidemiaamongpatientswithtype2diabetesinjordanprevalencepatternandassociatedfactors AT yousefkhader dyslipidemiaamongpatientswithtype2diabetesinjordanprevalencepatternandassociatedfactors AT mousaabujbara dyslipidemiaamongpatientswithtype2diabetesinjordanprevalencepatternandassociatedfactors AT mohammadelkhateeb dyslipidemiaamongpatientswithtype2diabetesinjordanprevalencepatternandassociatedfactors AT kamelajlouni dyslipidemiaamongpatientswithtype2diabetesinjordanprevalencepatternandassociatedfactors |